Showing results (151-160 of 176) with videos related to

Sort By:
Pageof 18
The British Journal of Psychiatry : the Journal of Mental Science|June 14, 2014
Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority studyW Wolfgang Fleischhacker, Raymond Sanchez, Pamela P Perry, et al.
Schizophrenia Bulletin|June 14, 2015
Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of SchizophreniaDavid Walling, Stephen R Marder, John Kane, et al.
Schizophrenia Bulletin|May 25, 2016
Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysisJian-Ping Zhang, Todd Lencz, Ryan X Zhang, et al.
Social Psychiatry and Psychiatric Epidemiology|February 2, 2010
Attitudes of patients with schizophrenia and depression to psychiatric research: a study in seven European countriesIngo Schäfer, Tom Burns, W Wolfgang Fleischhacker, et al.
The Journal of Clinical Psychiatry|March 29, 2008
Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challengesW Wolfgang Fleischhacker, Marcelo Cetkovich-Bakmas, Marc De Hert, et al.
Schizophrenia Research|February 22, 2005
Olfactory functions and volumetric measures of orbitofrontal and limbic regions in schizophreniaClaudia I Rupp, W Wolfgang Fleischhacker, Georg Kemmler, et al.
Schizophrenia Bulletin|March 10, 2015
Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for interventionRichard J Drake, Merete Nordentoft, Gillian Haddock, et al.
Focus (American Psychiatric Publishing)|January 31, 2020
The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for Its Methodology and a Review of the Effectiveness of Switching AntipsychoticsStefan Leucht, Inge Winter-van Rossum, Stephan Heres, et al.
Schizophrenia Research|February 8, 2022
Association between C-reactive protein levels and antipsychotic treatment during 12 months follow-up period after acute psychosisFarivar Fathian, Rolf Gjestad, Rune A Kroken, et al.
Schizophrenia Bulletin|March 20, 2015
The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychoticsStefan Leucht, Inge Winter-van Rossum, Stephan Heres, et al.
Pageof 18